Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria

European Cytokine Network

Volumn 11, Issue 1, 2000, Pages 113-118

  Akanmori, Bartholomew D ^a   Kurtzhals, Jørgen A L ^a,c   Goka, Bamenla Q ^b   Adabayeri, Victoria ^b   Ofori, Michael F ^a   Nkrumah, Francis K ^a   Behr, Charlotte ^d   Hviid, Lars ^c  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c Mental Health Services CPH   (Denmark)

^d INSTITUT PASTEUR   (France)

Author keywords

Anaemia; Cerebral; Malaria; TNF; TNF R1; TNF R2

Indexed keywords

CYTOKINE; INTERLEUKIN 10; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANEMIA; ARTICLE; BRAIN MALARIA; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE TRANSMISSION; GHANA; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PARASITEMIA; PATHOGENESIS; PLASMODIUM FALCIPARUM; PROTEIN BLOOD LEVEL;

ANEMIA; ANTIGENS, CD; CHILD; CHILD, PRESCHOOL; CYTOKINES; E-SELECTIN; GHANA; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON TYPE II; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKINS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; RECEPTORS, INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-4; RECEPTORS, INTERLEUKIN-6; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REGRESSION ANALYSIS; SIALOGLYCOPROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0034017361     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 1. Grau G E, Taylor TE, Molyneux M E, Wirima JJ, Vassali P, Hommel M, Lambert P H. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. New Engl. J. Med. 320: 1586.
2. 2. Kwiatkowski D, Hill A V, Sambou I, Twumasi P, Castracane J, Manogue K R, Cerami A, Brewster D R, Greenwood B M. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201.
3. 3. Clark I A, Chaudri G. 1988. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br. J. Haematol. 70: 99.
4. 4. Johnson R A, Waddelow T A, Caro J, Oliff A, Roodman G D. 1989. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood 74: 130.
5. 5. Miller K L, Silverman P H, Kullgren B, Mahlmann L J. 1989. Tumor necrosis factor alpha and the anemia associated with murine malaria. Infect. Immun. 57: 1542.
6. 6. Roodman G D, Bird A, Hutzler D, Montgomery W. 1987. Tumor necrosis factor-α and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells. Exp. Hematol. 15: 928.
7. 7. Taverne J, Sheikh N, de Souza J B, Playfair J H, Probert L, Kollias G. 1994. Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology 82: 397.
8. 8. McGuire W, Hill A V, Allsopp C E, Greenwood B M, Kwiatkowski D. 1994. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511.
9. 9. McGuire W, Knight J C, Hill A V, Allsopp C E, Greenwood B M, Kwiatkowski D. 1999. Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. J. Infect. Dis. 179: 287.
10. 10. Van Zee K J, Kohno T, Fischer E, Rock C S, Moldawer L L, Lowry S F. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor a in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89: 4845.
11. 11. Brockhaus M, Schoenfeld H J, Schlaeger H J, Hunziker W, Lesslauer W, Loetscher H. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87: 3127.
12. 12. Tartaglia L A, Weber R F, Figari I S, Reynolds C, Palladino M A Jr., Goeddel D V. 1991. The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad Sci. USA 88: 9292.
13. 13. Deloron P, Roux Lombard P, Ringwald P, Wallon W, Niyongabo T, Aubry P, Dayer JM, Peyron F. 1994. Plasma levels of TNF-α soluble receptors correlate with outcome in human falciparum malaria. Eur. Cytokine Netw. 5: 331.
14. 14. Jakobsen PH, McKay V, Morris-Jones S D, McGuire W, van Hensbroek M B, Meisner S, Bendtzen K, Schousboe I, Bygbjerg I C, Greenwood B M. 1994. Increased concentrations of interleukin-6 and interleukin-1 receptor antagonist and decreased concentrations of beta- 2-glycoprotein I in Gambian children with cerebral malaria. Infect. Immun. 62: 4374.
15. 15. Molyneux M E, Engelmann H, Taylor T E, Wirima J J, Aderka D, Wallach D, Grau G E. 1993. Circulating plasma receptors for tumour necrosis factor in Malawian children with severe falciparum malaria. Cytokine 5: 604.
16. 16. Lucas R, Juillard P, Decoster E, Redard M, Burger D, Donati Y, Giroud C, Monso-Hinard C, De Kesel T, Buurman W A, Moore M W, Dayer J M, Fiers W, Bluethmann H, Grau G E. 1997. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27: 1719.
17. 17. Kurtzhals J A, Adabayeri V, Goka B Q, Akanmori B D, Oliver-Commey J O, Nkrumah F K, Behr C, Hviid L. 1998. Low plasma concentrations of interleukin-10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet 351: 1768.
18. 18. Afari E A, Appawu M, Dunyo S, Baffoe-Wilmot A, Nkrumah F K. 1995. Malaria infection, morbidity and transmission in two ecological zones in southern Ghana. Afr. J. Health Sci. 2: 312.
19. 19. Kwiatkowski D, Molyneux M E, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster D R, Grau G E, Greenwood B M. 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 86: 91.
20. 20. Grau C E, Fajardo L F, Piguet P F, Allet B, Lambert P H, Vassalli P. 1987. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science 237: 1210.
21. 21. Othoro C, Lal A A, Nahlen B, Koech D, Orago A S, Udhayakumar V. 1999. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J. Infect. Dis. 179: 279.
22. 22. Jakobsen P H, Morris-Jones S, Theander T G, Hviid L, Hansen M B, Bendtzen K, Ridley R G, Greenwood B M. 1994. Increased plasma levels of soluble IL-2R are associated with severe Plasmodium falciparum malaria. Clin. Exp. Immunol. 96: 98.
23. 23. Kern P, Hemmer C J, Gallati H, Neifer S, Kremsner P, Dietrich M, Porzsolt F. 1992. Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J. Infect. Dis. 166: 930.
24. 24. Garcia I, Miyazaki Y, Araki K, Araki M, Lucas R, Grau G E, Milon G, Belkaid Y, Montixi C, Lesslauer W, Vassalli P. 1995. Transgenic mice expressing high levels of soluble TNF-RI fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections. Eur. J. Immunol. 25:2401.
25. 25. McGuire W, D'Alessandro U, Stephens S, Olaleye B O, Langerock P, Greenwood B M, Kwiatkowski D. 1998. Levels of tumour necrosis factor and soluble TNF receptors during malaria fever episodes in the community. Trans. R. Soc. Trop. Med. Hyg. 92: 50.
26. 26. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries J E. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174: 1209.
27. 27. Ho M, Schollaardt T, Snape S, Looareesuwan S, Suntharasatnai P, White N J. 1998. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J. Infect. Dis. 178: 520.
28. 28. Kwiatkowski D. 1989. Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. J. Exp. Med. 169: 357.
29. 29. Clark I A, Cowden W B. Roles of TNF in malaria and other parasitic infections, p, 365-407. In: Aggarwal B B, Vilcek J., Eds. Tumor necrosis factors. Structure, function, and mechanisms of action. New York: Marcel Dekker, Inc., 600 p.